DKK1 and neoplasm: Finally, we wanted to define whether mDKN‐01 shows efficacy in a more pathologically relevant, damage‐induced model of iCCA where tumours develop on the background of chronically inflamed liver with endogenous levels of DKK1, thereby better reflecting human disease aetiology.